 
			
			FDA has plans to overcome challenges in building medical device surveillance system, GAO says
				The watchdog offered a new assessment of the agency’s work to establish an active postmarket surveillance system to monitor the safety and efficacy of medical devices.			
		
		
				
		
		
	 
			 
			 
			 
			